Stifel Financial’s Twist Bioscience TWST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.22M Buy
11,861
+4,302
+57% +$280K ﹤0.01% 2423
2026
Q1
$359K Sell
7,559
-210
-3% -$9.41K ﹤0.01% 3065
2025
Q4
$246K Buy
7,769
+271
+4% +$8.46K ﹤0.01% 3272
2025
Q3
$211K Buy
7,498
+917
+14% +$27.8K ﹤0.01% 3314
2025
Q2
$242K Sell
6,581
-2,074
-24% -$71.7K ﹤0.01% 3164
2025
Q1
$340K Buy
8,655
+324
+4% +$14.6K ﹤0.01% 2905
2024
Q4
$387K Buy
8,331
+1,364
+20% +$61.6K ﹤0.01% 2826
2024
Q3
$315K Buy
6,967
+734
+12% +$34.9K ﹤0.01% 2934
2024
Q2
$307K Sell
6,233
-556
-8% -$22.7K ﹤0.01% 2908
2024
Q1
$233K Buy
+6,789
New +$245K ﹤0.01% 3033

Other funds holding TWST

Stifel Financial's TWST Position: Q2 2026 in Review

Stifel Financial increased its Twist Bioscience (TWST) stake by 57% in Q2 2026, buying an estimated $280K and bringing the position to 11,861 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2423.

Stifel Financial first reported a position in TWST in Q1 2024 and has held it in 10 quarters since. 337 funds tracked by Wall St. Rank hold TWST as of Q2 2026.

  • Stifel Financial held 11,861 shares of Twist Bioscience worth $1.22M as of Q2 2026.
  • Stifel Financial bought 4,302 Twist Bioscience shares in Q2 2026, an estimated $280K.
  • Twist Bioscience made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2423 holding.
  • Stifel Financial first reported a position in Twist Bioscience in Q1 2024 and has held it in 10 quarters since.
  • 337 funds tracked by Wall St. Rank held Twist Bioscience as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.